Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
Authors
Keywords
-
Journal
AIDS
Volume 25, Issue 17, Pages 2167-2175
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-10-05
DOI
10.1097/qad.0b013e32834c4adb
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting
- (2011) Claudia Hawkins et al. AIDS
- First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration
- (2010) Julia Drylewicz et al. AIDS
- HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form
- (2010) Thushan I de Silva et al. Retrovirology
- Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village
- (2010) Maarten van der Loeff et al. Retrovirology
- Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy
- (2010) Philippa J Easterbrook et al. Journal of the International AIDS Society
- Rapid scaling-up of antiretroviral therapy in 10 000 adults in Côte dʼIvoire: 2-year outcomes and determinants
- (2009) Siaka Toure et al. AIDS
- Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France
- (2009) Julia Drylewicz et al. AIDS
- Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients
- (2009) Antoine Bénard et al. AIDS
- Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2
- (2009) M. L. Ntemgwa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Multiclass Drug–Resistance in HIV‐2 in Antiretroviral‐Treated Individuals in Senegal: Implications for HIV‐2 Treatment in Resouce‐Limited West Africa
- (2009) Geoffrey S. Gottlieb et al. CLINICAL INFECTIOUS DISEASES
- Effect of HIV‐1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
- (2009) Anna Maria Geretti et al. CLINICAL INFECTIOUS DISEASES
- Loss to Care and Death Before Antiretroviral Therapy in Durban, South Africa
- (2009) Ingrid V Bassett et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study
- (2009) F. S. Sarfo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV-2) and in Patients Dually Infected with HIV-1 and HIV-2 in The Gambia and Emergence of Drug-Resistant Variants
- (2009) S. Jallow et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
- (2009) John A Bartlett et al. LANCET INFECTIOUS DISEASES
- Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso
- (2009) Katie Harries et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- The impact of gender and income on survival and retention in a South African antiretroviral therapy programme
- (2009) Morna Cornell et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996–2008)
- (2009) Jorge L Martinez-Cajas et al. Journal of the International AIDS Society
- Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
- (2008) Stephen D Lawn et al. AIDS
- Excessive Early Mortality in the First Year of Treatment in HIV Type 1-Infected Patients Initiating Antiretroviral Therapy in Resource-Limited Settings
- (2008) Maria Cristina Marazzi et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- In Vitro Phenotypic Susceptibility of Human Immunodeficiency Virus Type 2 Clinical Isolates to Protease Inhibitors
- (2008) D. Desbois et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study
- (2008) Katherine L Fielding et al. BMC INFECTIOUS DISEASES
- Efficacy of Antiretroviral Therapy in Africa: Effect on Immunological and Virological Outcome Measures – A Meta-Analysis
- (2008) Rebecca Hammond et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Quality Control Assessment of Human Immunodeficiency Virus Type 2 (HIV-2) Viral Load Quantification Assays: Results from an International Collaboration on HIV-2 Infection in 2006
- (2008) F. Damond et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mortality and loss to follow-up among HAART initiators in rural South Africa
- (2008) Peter MacPherson et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now